| Views | |
|---|---|
| Assessment of the nephroprotective properties of the erythropoietin mimetic peptide and infliximab in kidney ischemia-reperfusion injury in rat | 42 |
| October 2024 | November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | |
|---|---|---|---|---|---|---|---|
| Assessment of the nephroprotective properties of the erythropoietin mimetic peptide and infliximab in kidney ischemia-reperfusion injury in rat | 3 | 2 | 1 | 1 | 3 | 2 | 0 |
| Views | |
|---|---|
| Netrebenko_Assessment.pdf | 18 |
| Views | |
|---|---|
| Canada | 8 |
| United States | 8 |
| Australia | 1 |
| Germany | 1 |
| EU | 1 |
| Hong Kong | 1 |
| South Korea | 1 |
| Russia | 1 |
| Views | |
|---|---|
| Ottawa | 8 |
| Mountain View | 3 |
| Ann Arbor | 1 |
| Baltimore | 1 |
| Central District | 1 |
| Coburg | 1 |
| Mytishchi | 1 |
| Washington | 1 |